SGRY Surgery Partners, Inc. Common Stock
XNAS 23.25 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
SGRY
$23.25
—
Key stats
$23.25
- 52-Week Range
- $11.41 – $23.44
- YTD
- +52.36%
- IV Rank (30D)
- 0.0
- Straddle Price
- $0.93
- P/C Vol Ratio
- 5.57
- Market Cap
- $2.1B
- Open
- $23.03
- Day Range
- $22.94 – $23.29
- Volume
- 58,819,607
- Prev Close
- $15.75
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.13% |
| Beta vs SPY | 1.41 |
| Cost of Equity (CAPM) | 12.90% (VRP-adj) |
| WACC | 8.20% |
| Volatility Risk Premium | +71.4pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 14.7% |
| Rev. Growth (YoY, DCF input) | -1.9% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $0.2B |
| Return on Equity (TTM) | -5.3% |
| Book / Price | 154.3% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 100.0% |
| FCF Margin (TTM) | 5.6% |
| Debt / Equity | 1.17 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +10.4% (reverse-DCF on current price) |
| SMA 50 | $14.23 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $14.39 |
| Bollinger Width / SMA20 | 156.4% (drives anchor stability) |
| Net Debt | $3.4B |
| Market Cap | $2B |
Peers used for multiples: CI, CNC, ELV, HUM, MOH, OPCH, UNH
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
97%
20-Day Fair Value
≈ by Nov 24, 2026
$23.99
α +3.2%
rank 96%
conviction
98%
40-Day Fair Value
≈ by Dec 23, 2026
$24.67
α +6.1%
rank 98%
conviction
100%
60-Day Fair Value
≈ by Jan 21, 2027
$24.65
α +6.0%
rank 96%
conviction
97%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $-6.62 | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 22.4× · 5 peers |
| Peer EV/EBITDA | $44.47 | 28% | median 13.9× · 7 peers |
| Peer P/B | $63.93 | 36% | median 2.6× · 7 peers |
| Peer P/S | $9.18 | 36% | median 0.3× · 7 peers |
| Market Anchor (SMA50) | $14.23 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $15.94 | 0% | 8 strikes · skew -0.05 |
As of 2026-10-26 · updated
Related
About
- Industry (SIC)
- SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC (8062) · industry map
- Exchange
- XNAS
- Market Cap
- $2.1B
- Employees
- 16,000
- List Date
- 2015-10-01
- CIK
- 0001638833
- Next Earnings
- 2026-11-09 (Pre-Market)
- EPS Forecast
- ($0.03) (2 est.)
- Headquarters
- Brentwood, TN
- Homepage
- https://www.surgerypartners.com
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 35.07% | -22.52% | 26.24% | -2.97% | 19.73% | -2.62% | 8.82% |
| Feb | -4.01% | 16.67% | -3.49% | -4.61% | -4.82% | 4.73% | 0.75% |
| Mar | 6.78% | 1.12% | 1.41% | -4.36% | -1.04% | -24.94% | -3.51% |
| Apr | 10.55% | -7.69% | 14.86% | -13.61% | -6.52% | 14.44% | 2.01% |
| May | 16.76% | -23.47% | -4.80% | 12.06% | 5.26% | -6.38% | -0.09% |
| Jun | 11.37% | -23.27% | 17.90% | -10.19% | -4.96% | 27.08% | 2.99% |
| Jul | -16.32% | 25.90% | -11.50% | 29.69% | -2.66% | -8.42% | 2.78% |
| Aug | -9.79% | -26.68% | -1.84% | 5.72% | 6.63% | -13.51% | -6.58% |
| Sep | -15.83% | -10.21% | -21.73% | 2.58% | -4.16% | -5.00% | -9.06% |
| Oct | -8.78% | 9.42% | -20.87% | -11.36% | 3.52% | 75.74%* | 7.94% |
| Nov | 8.75% | 0.57% | 44.59% | -17.08% | -21.34% | -- | 3.10% |
| Dec | 26.09% | -2.45% | -6.05% | -11.09% | -9.65% | -- | -0.63% |
| Total | 58.17% | -55.91% | 16.42% | -29.26% | -22.82% | 37.83% | 0.74% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $14.82
SMA 50: $14.39
SMA 200: $14.48
Current: $23.25
EMA 12: $16.25
EMA 26: $15.24
MACD: 1.0132 | Signal: 0.6718
BULLISH
ADX (14): 28.74
TREND
+DI: 62.89
−DI: 5.88
Momentum Oscillators
RSI (14): 87.34
OVERBOUGHT
Stoch %K: 94.04
Stoch %D: 93.44
Williams %R: -0.40
Volume & Volatility
BB Upper: $19.01
BB Lower: $10.62
OVERBOUGHT
OBV: 59,230,115
Vol SMA 20: 4,646,635
Vol ROC: 4750.81%
ATR: $1.12
True Range: $7.54
HV 20: 141.8%
HV 30: 127.4%
HV 60: 96.4%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL with confidence level 6/10
Key Drivers:
- Recent negative earnings release and news headlines weighing on stock
- High volatility, potentially amplifying market movements
- Bullish momentum signals from MACD, but neutral RSI reading
Primary Risks:
- Downside risk due to recent negative news and high volatility
- Potential for further declines if market sentiment remains bearish
Investment Thesis: SGRY's stock price may experience a range-bound trading environment, with potential for mean reversion and a return to the upper end of its historical trading range. However, the recent earnings miss and negative news headlines pose a significant risk to the stock.
Recent News Sentiment Impact: The recent news headlines have been predominantly negative, which has contributed to the stock's decline. The positive market narrative around ambulatory surgical centers may provide some support, but it is unclear if this trend will be sustained in the near term.
Technical Analysis
Trend Direction:
- Short-term: NEUTRAL (range-bound)
- Medium-term: BEARISH (downward trending)
- Long-term: NEUTRAL (historical range)
Support/Resistance Levels:
- Lower band: $13.22
- Middle line: $13.97
- Upper band: $14.72
Momentum Signals:
- RSI interpretation: NEUTRAL (49.19)
- MACD signal: BULLISH (bullish crossover)
- Bollinger Bands position: NEUTRAL (signal)
Volume Analysis:
- Volume SMA 20: 1744085.10
- On-Balance Volume (OBV): -38793018.13
- Volume Rate of Change: -78.27%
News & Sentiment Analysis
Recent Headlines Summary: Recent news has been predominantly negative, with earnings misses and regulatory issues weighing on the stock.
Sentiment Assessment: NEGATIVE sentiment overall, driven by recent news headlines and high volatility.
Catalyst Identification: No significant catalysts identified in the near term, but the market narrative around ambulatory surgical centers may provide some support.
Market Narrative: The market narrative is mixed, with negative news headlines weighing on the stock, while the positive trend in ambulatory surgical centers provides some support.
Risk & Volatility Assessment
Beta Interpretation: SGRY has a beta of 1.04, indicating above-average volatility relative to the broader market.
Volatility Regime: High volatility regime, with a True Range of $0.45 and IV Premium vs HV30 at 352.8%.
Options Market Signals: Options market is pricing in a potential move of $1.35 by expiration, with a put-call volume ratio of 1.00 indicating neutral sentiment.
Market Context & Positioning
Sector Performance: Ambulatory surgical centers sector has been trending upward, which may provide some support to SGRY's stock price.
Institutional Activity: Institutional activity is unclear, but the recent earnings miss and negative news headlines may have led institutions to reduce their positions in the stock.
Correlation Analysis: SGRY has a correlation of 0.27 with SPY, indicating that it moves with the broader market, but with an amplification factor due to its high volatility.
Key Levels & Action Items
Critical Price Levels:
- Lower band: $13.22
- Middle line: $13.97
- Upper band: $14.72
Breakout/Breakdown Levels: A breakout above the upper band or a breakdown below the lower band could trigger significant moves.
Time-Sensitive Catalysts: No specific time-sensitive catalysts identified, but the upcoming earnings release date and conference call details may provide some insight into the company's future performance.
Risk Management: Stop-loss levels should be set around $13.00 to limit potential losses, with position sizing considerations based on volatility and market sentiment.
Generated
News
All SGRY news →
HealthSpan Partners agreed to buy the outpatient surgery center operator for $5.7 billion in cash, valuing shares at $23.50, today, Oct. 26, 2026.
Bain Capital-backed Surgery Partners operates through a network of ambulatory surgery centers, surgical hospitals and physician partnerships.
Surgery Partners Inc. will be acquired by an affiliate of Bon Secours Mercy Health for an enterprise value of $5.7 billion, giving one of the country’s largest nonprofit hospital systems a deeper reach into outpatient surgical care.
Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, valuing the group at about $20 a share, the Financial Times reports, citing people familiar with the matter.
Showing 1–10 of 12
Page 1 of 2
Earnings History
17 of 22 under expected move
Avg Expected Move
10.62%
Avg Actual Move
6.58%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-01-11 | Pre-Market | 1.81% | 3.56% | 1.97x | Exceeded |
| 2021-03-10 | Pre-Market | 11.70% | 3.55% | 0.30x | Within |
| 2021-05-05 | Pre-Market | 11.64% | 1.82% | 0.16x | Within |
| 2021-08-04 | Pre-Market | 12.23% | 14.96% | 1.22x | Exceeded |
| 2022-01-10 | Pre-Market | 1.77% | 1.06% | 0.60x | Within |
| 2022-05-03 | Pre-Market | 10.93% | 7.20% | 0.66x | Within |
| 2023-01-09 | Pre-Market | 15.80% | 2.69% | 0.17x | Within |
| 2023-03-01 | Pre-Market | 5.68% | 1.61% | 0.28x | Within |
| 2023-08-01 | Pre-Market | 7.25% | 4.37% | 0.60x | Within |
| 2023-11-07 | Pre-Market | 14.75% | 13.99% | 0.95x | Within |
| 2024-01-08 | Pre-Market | 8.31% | 9.40% | 1.13x | Exceeded |
| 2024-02-26 | Pre-Market | 12.56% | 8.60% | 0.68x | Within |
| 2024-05-07 | Pre-Market | 12.62% | 8.48% | 0.67x | Within |
| 2024-08-06 | Pre-Market | 17.15% | 3.20% | 0.19x | Within |
| 2024-11-12 | After-Close | 4.48% | 13.75% | 3.07x | Exceeded |
| 2025-03-03 | Pre-Market | 9.45% | 0.33% | 0.03x | Within |
| 2025-05-12 | Pre-Market | 15.46% | 4.96% | 0.32x | Within |
| 2025-08-05 | Pre-Market | 6.86% | 0.34% | 0.05x | Within |
| 2025-11-10 | Pre-Market | 9.65% | 25.42% | 2.63x | Exceeded |
| 2026-03-02 | After-Close | 12.91% | 12.34% | 0.96x | Within |
| 2026-05-05 | Pre-Market | 16.37% | 0.42% | 0.03x | Within |
| 2026-08-10 | Pre-Market | 14.17% | 2.70% | 0.19x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
SGRY Options Activity & IV Rank
SGRY IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 22.6%
7-DTE IV: —
Expected Move: $0.93
7-DTE Move: $0.93
Days to Exp: 25 (2026-11-20)
Options Flow
Call Volume: 165
Put Volume: 919
P/C Volume: 5.57
BEARISH
Call OI: 431
Put OI: 92
P/C OI: 0.213
Total OI: 523
ATM Options Pricing
ATM Call: $0.90
ATM Put: $0.03
Call %: 3.9%
Put %: 0.1%
Chain Summary
Chain Volume: 2,951
Chain OI: 5,066
Last Updated: 10/26/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 96th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
96%
vs own history
GEX tilt
+1.00
OI-weighted, today
Vanna tilt
+1.00
δ-sensitivity to IV
Charm tilt
-1.00
δ-decay vs time
Vanna tilt +1.00: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -1.00: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 3 ATM contracts, 2k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 26 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Oct 26 · ATM 14.9% / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)0.0LowOct 26
Straddle Price (30 DTE)$0.93Oct 26
Beta Analysis
Risk Metrics
Beta: 0.8428
Alpha: 13.64%
Correlation: 0.1525
R-Squared: 2.3%
Stock Volatility: 70.4%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Notable investors who own SGRY
4 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Oaktree Capital Asset manager Howard Marks | $14.5M | #60 of 130 | new | 13F | |
| Citadel Hedge fund Ken Griffin | $4.9M | #2112 of 6285 | -27.5% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $2.2M | #1911 of 3138 | new | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $65K | #3229 of 4729 | 0.0% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
SGRY Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 127,440,500 (as of 2026-03-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
10 filers$12.52M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | LMR Partners LLP | $3.36M | 26.83% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $3.10M | 24.74% | 2026-06-30 |
| 3 | Centiva Capital, LP | $2.71M | 21.65% | 2026-06-30 |
| 4 | Wolverine Trading, LLC Custodian | $1.95M | 15.61% | 2025-09-30 |
| 5 | Susquehanna International Group, LLP Custodian | $582.96K | 4.66% | 2026-06-30 |
| 6 | Foundations Investment Advisors, LLC | $336.00K | 2.68% | 2026-06-30 |
| 7 | IMC-Chicago, LLC Custodian | $262.08K | 2.09% | 2026-06-30 |
| 8 | Walleye Capital LLC | $124.32K | 0.99% | 2026-06-30 |
| 9 | Simplex Trading, LLC Custodian | $63.84K | 0.51% | 2026-06-30 |
| 10 | GROUP ONE TRADING LLC Custodian | $28.56K | 0.23% | 2026-06-30 |
3 filers$3.40M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Wolverine Trading, LLC Custodian | $2.64M | 77.44% | 2025-09-30 |
| 2 | Crawford Fund Management, LLC | $722.40K | 21.23% | 2026-06-30 |
| 3 | Walleye Capital LLC | $45.36K | 1.33% | 2026-06-30 |
SGRY Insider Trading (Form 4)
Latest: 2026-08-20Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Teresa DeLuca | Director | Buy (P) | +11,250 | $14.33 | $161.2K | EDGAR |
| 2026-08-19 | Teresa DeLuca | Director | Buy (P) | +10,000 | $14.35 | $143.5K | EDGAR |
| 2026-07-14 | Blair E Hendrix | Director | Award (A) | +34,364 | $14.55 | $500.0K | EDGAR |
| 2026-06-09 | Teresa DeLuca | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | Brent Turner | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | Blair E Hendrix | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | Clifford G Adlerz | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | John A Deane | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | Laura L Forese | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | Lloyd H Dean | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-03-16 | Jennifer Baldock | Chief Admin & Dev Officer | Sell (S) | −5,798 | $13.17 | -$76.4K | EDGAR |
| 2026-03-16 | Marissa Brittenham | Chief Strategy Officer | Sell (S) | −3,657 | $12.54 | -$45.9K | EDGAR |
| 2026-03-16 | Jason Eric Evans | Chief Executive Officer | Sell (S) | −20,400 | $12.47 | -$254.4K | EDGAR |
| 2026-03-16 | Danielle Burkhalter | Chief Human Resources Officer | Sell (S) | −3,469 | $12.83 | -$44.5K | EDGAR |
| 2026-03-16 | David T Doherty | Chief Financial Officer | Sell (S) | −8,867 | $12.50 | -$110.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
SGRY Insider Holdings
17 insiders · @ $23.25
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Blair E Hendrix | Director | 49,999,867 | $1.16B | -$261.73M | 5 | 2026-07-14 |
| 2 | Jason Eric Evans | Chief Executive Officer | 920,386 | $21.40M | -$6.16M | 34 | 2026-03-16 |
| 3 | Jennifer Baldock | Chief Admin & Dev Officer | 326,474 | $7.59M | -$4.75M | 39 | 2026-03-16 |
| 4 | David T Doherty | Chief Financial Officer | 221,679 | $5.15M | -$3.65M | 23 | 2026-03-16 |
| 5 | Harrison R. Bane | National Group President | 120,794 | $2.81M | -$2.24M | 10 | 2025-09-08 |
| 6 | Justin Robert Oppenheimer | COO & National Group President | 120,259 | $2.80M | $0 | 2 | 2026-03-09 |
| 7 | Wayne S DeVeydt | Exec Chairman of the Board | 105,203 | $2.45M | -$9.79M | 19 | 2025-03-25 |
| 8 | Marissa Brittenham | Chief Strategy Officer | 94,196 | $2.19M | -$757.0K | 12 | 2026-03-16 |
| 9 | Brent Turner | Director | 86,594 | $2.01M | $245.0K | 12 | 2026-06-09 |
| 10 | Danielle Burkhalter | Chief Human Resources Officer | 76,864 | $1.79M | -$427.8K | 14 | 2026-03-16 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
SGRY Board & Officers
As of SEC filings through Aug 20, 2026Directors 9
- Brent Turner · since Dec 30, 2015
- Teresa DeLuca · since Sep 30, 2016
- T. Devin O'Reilly · since Aug 31, 2017
- Clifford G Adlerz · listed since Aug 2018
- John A Deane · since May 29, 2019
- Patricia Anne Maryland · since Mar 10, 2021
- Blair E Hendrix · on file since Nov 2022
- Laura L Forese · since Jan 10, 2025
- Lloyd H Dean · since Feb 26, 2026
Officers 7
- Jason Eric Evans · Chief Executive Officer · listed since Mar 2020
- William Trenton Webb · American Group President · since Sep 1, 2024
- Justin Robert Oppenheimer · COO & National Group President · since Jan 1, 2026
- David T Doherty · Chief Financial Officer · since Feb 1, 2022
- Jennifer Baldock · Chief Admin & Dev Officer · listed since Feb 2020
- Marissa Brittenham · Chief Strategy Officer · since Jan 10, 2022
- Danielle Burkhalter · Chief Human Resources Officer · since Jan 19, 2023
10% owners 1
- Blair E Hendrix · on file since Nov 2022
Changes in the last 10 years (74)
| Feb 26, 2026 | Lloyd H Dean became a director |
| Jan 1, 2026 | Justin Robert Oppenheimer became COO & National Group President |
| Sep 11, 2025 | The company announced the departure of Harrison R. Bane as National Group President in an SEC filing |
| Aug 4, 2025 | The company announced the departure of Wayne S DeVeydt from the board in an SEC filing |
| Aug 4, 2025 | The company announced the departure of Wayne S DeVeydt as Exec Chairman of the Board in an SEC filing |
| Jan 10, 2025 | Laura L Forese became a director |
| Sep 4, 2024 | Harrison R. Bane listed as National Group President (previously American Group President) in SEC filings |
| Sep 1, 2024 | William Trenton Webb became American Group President |
| Dec 21, 2023 | BCPE Seminole Holdings IV, L.P. first on file as a director |
| Dec 21, 2023 | BCPE Seminole Holdings IV, L.P. first on file as a 10% owner |
| Dec 21, 2023 | BCPE Seminole Holdings III, L.P. first on file as a director |
| Dec 21, 2023 | BCPE Seminole Holdings III, L.P. first on file as a 10% owner |
| Dec 21, 2023 | BCPE Seminole Holdings II Intermediate LP first on file as a director |
| Dec 21, 2023 | BCPE Seminole Holdings II Intermediate LP first on file as a 10% owner |
| Dec 21, 2023 | BCPE Seminole GP III LLC first on file as a director |
| Dec 21, 2023 | BCPE Seminole GP III LLC first on file as a 10% owner |
| Dec 21, 2023 | BCPE Seminole GP II LLC first on file as a director |
| Dec 21, 2023 | BCPE Seminole GP II LLC first on file as a 10% owner |
| Dec 21, 2023 | Andrew T. Kaplan first listed as a 10% owner in an SEC filing |
| Jan 19, 2023 | Danielle Burkhalter became Chief Human Resources Officer |
| Nov 23, 2022 | Blair E Hendrix first on file as a director |
| Nov 23, 2022 | Blair E Hendrix first on file as a 10% owner |
| Nov 23, 2022 | Bain Capital Partners XI, L.P. first on file as a director |
| Nov 23, 2022 | Bain Capital Partners XI, L.P. first on file as a 10% owner |
| Nov 23, 2022 | Bain Capital Fund XI, L.P. first on file as a director |
| Nov 23, 2022 | Bain Capital Fund XI, L.P. first on file as a 10% owner |
| Sep 30, 2022 | Harrison R. Bane became American Group President |
| Apr 25, 2022 | George Goodwin listed as American Group President (previously President, ASC Group) in SEC filings |
| Feb 1, 2022 | David T Doherty became Chief Financial Officer |
| Jan 10, 2022 | Marissa Brittenham became Chief Strategy Officer |
| Mar 10, 2021 | Patricia Anne Maryland became a director |
| Jan 1, 2021 | Laura L. Brocklehurst became Chief Human Resources Officer |
| Jan 1, 2021 | Bradley R. Owens became National Group President |
| Mar 17, 2020 | Jason Eric Evans listed as Chief Executive Officer (previously EVP & Chief Operating Officer) in SEC filings |
| Mar 17, 2020 | George Goodwin listed as President, ASC Group (previously President, American Group) in SEC filings |
| Feb 7, 2020 | Wayne S DeVeydt listed as Exec Chairman of the Board (previously Chief Executive Officer) in SEC filings |
| Feb 7, 2020 | Jennifer Baldock listed as Chief Admin & Dev Officer (previously EVP & Chief Legal Officer) in SEC filings |
| Feb 7, 2020 | Anthony Taparo listed as Chief Growth Officer (previously President, Atlantic Group) in SEC filings |
| Jul 3, 2019 | Angela Justice reported in an SEC filing no longer being Chief Human Resources Officer |
| May 29, 2019 | John A Deane became a director |
| Apr 3, 2019 | R. David Kretschmer reported in an SEC filing no longer being CSTO; Interim CFO |
| Apr 1, 2019 | Jason Eric Evans became EVP & Chief Operating Officer |
| Mar 19, 2019 | Jennifer Baldock listed as EVP & Chief Legal Officer (previously Sr. VP, Gen Couns. & Sec.) in SEC filings |
| Mar 15, 2019 | Carollee Brinkman became President, National Group |
| Sep 5, 2018 | Bryan S Fisher reported in an SEC filing no longer being EVP, COO of SP Ntl Grp |
| Aug 31, 2018 | Andrew T. Kaplan became a director |
| Aug 28, 2018 | Clifford G Adlerz no longer listed as Interim CEO in SEC filings |
| Aug 28, 2018 | Clifford G Adlerz first listed as a director in an SEC filing |
| Apr 19, 2018 | Ronald P. Zelhof became Senior VP, Operations |
| Apr 19, 2018 | George Goodwin became President, American Group |
| Apr 19, 2018 | Brandan Lingle became Pres., Ancillary Svces. Grp. |
| Apr 19, 2018 | Anthony Taparo became President, Atlantic Group |
| Apr 2, 2018 | Thomas F. Cowhey became Chief Financial Officer |
| Mar 12, 2018 | Angela Justice became Chief Human Resources Officer |
| Feb 12, 2018 | R. David Kretschmer became CSTO; Interim CFO |
| Jan 4, 2018 | Wayne S DeVeydt became a director |
| Jan 4, 2018 | Wayne S DeVeydt became Chief Executive Officer |
| Sep 7, 2017 | Clifford G Adlerz became Interim CEO |
| Sep 5, 2017 | Sami Mnaymneh reported in an SEC filing no longer being a 10% owner |
| Sep 5, 2017 | Hig Gp II Inc reported in an SEC filing no longer being a 10% owner |
| Sep 5, 2017 | H.I.G. Surgery Centers, LLC reported in an SEC filing no longer being a 10% owner |
| Sep 5, 2017 | Anthony Tamer reported in an SEC filing no longer being a 10% owner |
| Aug 31, 2017 | T. Devin O'Reilly became a director |
| Aug 31, 2017 | T. Devin O'Reilly became a 10% owner |
| Aug 31, 2017 | Christopher R Gordon became a director |
| Aug 31, 2017 | Christopher R Gordon became a 10% owner |
| Aug 31, 2017 | Bryan S Fisher became EVP, COO of SP Ntl Grp |
| Aug 31, 2017 | Benjamin F Jacobs became CDO, Grp Pres of SP |
| Aug 31, 2017 | Bain Capital Investors LLC became a director |
| Aug 31, 2017 | Bain Capital Investors LLC became a 10% owner |
| Aug 31, 2017 | BCPE Seminole Holdings LP became a director |
| Aug 31, 2017 | BCPE Seminole Holdings LP became a 10% owner |
| Aug 31, 2017 | BCPE Seminole GP LLC became a director |
| Aug 31, 2017 | BCPE Seminole GP LLC became a 10% owner |
Not reported recently (26)
- Bradley R. Owens · Last reported as National Group President in an SEC filing dated Jun 3, 2024
- Andrew T. Kaplan · Last reported as a director in an SEC filing dated Apr 8, 2024
- Anthony Taparo · Last reported as Chief Growth Officer in an SEC filing dated Mar 13, 2024
- BCPE Seminole Holdings LP · Last reported as a director in an SEC filing dated Dec 21, 2023
- BCPE Seminole GP LLC · Last reported as a director in an SEC filing dated Dec 21, 2023
- Bain Capital Investors LLC · Last reported as a director in an SEC filing dated Dec 21, 2023
- BCPE Seminole Holdings II Intermediate LP · Last reported as a director in an SEC filing dated Dec 21, 2023
- BCPE Seminole Holdings IV, L.P. · Last reported as a director in an SEC filing dated Dec 21, 2023
- BCPE Seminole Holdings III, L.P. · Last reported as a director in an SEC filing dated Dec 21, 2023
- BCPE Seminole GP II LLC · Last reported as a director in an SEC filing dated Dec 21, 2023
- BCPE Seminole GP III LLC · Last reported as a director in an SEC filing dated Dec 21, 2023
- Bain Capital Partners XI, L.P. · Last reported as a director in an SEC filing dated Nov 23, 2022
- Bain Capital Fund XI, L.P. · Last reported as a director in an SEC filing dated Nov 23, 2022
- Laura L. Brocklehurst · Last reported as Chief Human Resources Officer in an SEC filing dated Nov 14, 2022
- George Goodwin · Last reported as American Group President in an SEC filing dated Jun 8, 2022
- Thomas F. Cowhey · Last reported as Chief Financial Officer in an SEC filing dated May 7, 2021
- Adam T Feinstein · Last reported as a director in an SEC filing dated May 20, 2019
- Brandan Lingle · Last reported as Pres., Ancillary Svces. Grp. in an SEC filing dated Apr 8, 2019
- Carollee Brinkman · Last reported as President, National Group in an SEC filing dated Mar 19, 2019
- Ronald P. Zelhof · Last reported as Senior VP, Operations in an SEC filing dated Apr 25, 2018
- Dennis Dean · Last reported as Senior VP & Controller in an SEC filing dated Apr 5, 2018
- Teresa Sparks · Last reported as Executive VP & CFO in an SEC filing dated Jan 3, 2018
- John Crysel · Last reported as Group Pres., National Group in an SEC filing dated Jan 3, 2018
- Michael Thomas Doyle · Last reported as a director in an SEC filing dated Nov 15, 2017
- Christopher R Gordon · Last reported as a director in an SEC filing dated Sep 1, 2017
- Benjamin F Jacobs · Last reported as CDO, Grp Pres of SP in an SEC filing dated Aug 31, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
SGRY Proposed Insider Sales (Form 144)
Latest: 2026-03-16
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | David Doherty | Officer | 8,867 | $110.8K | 2026-03-16 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-16 | Jason Eric Evans | Director, Officer | 20,400 | $254.4K | 2026-03-16 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-13 | Marissa Brittenham | Officer | 3,657 | $45.9K | 2026-03-13 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-13 | Danielle Burkhalter | Officer | 3,469 | $44.5K | 2026-03-13 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-12 | William T. Webb | Officer | 2,045 | $26.7K | 2026-03-12 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-12 | Jennifer Baldock | Officer | 5,798 | $76.4K | 2026-03-12 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-06 | David Doherty | Officer | 14,574 | $201.7K | 2026-03-06 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-06 | William T. Webb | Officer | 272 | $3.8K | 2026-03-06 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-06 | Jason Eric Evans | Officer, Director | 11,462 | $158.1K | 2026-03-06 | UBS Financial Services Inc | — | EDGAR |
| 2026-03-06 | Marissa Brittenham | Officer | 8,785 | $120.4K | 2026-03-06 | UBS Financial Services Inc | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
60 ETFs hold SGRY
25 shown · $246.83M total exposure · 0.03% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.14% | $37.3M | — | 2026-10-23 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $34.4M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.04% | $31.5M | $74.6B | 2026-10-23 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.01% | $24.5M | — | 2026-09-30 |
| 5 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.06% | $19.4M | — | 2026-10-23 |
| 6 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.02% | $16.0M | — | 2026-09-30 |
| 7 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.04% | $13.7M | — | 2026-10-23 |
| 8 | VXF Vanguard Extended Market ETF | Vanguard | 0.01% | $12.1M | — | 2026-09-30 |
| 9 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.08% | $11.6M | $13.9B | 2026-10-23 |
| 10 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.04% | $6.5M | — | 2026-09-30 |
| 11 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.02% | $4.9M | — | 2026-05-31 |
| 12 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.06% | $4.8M | — | 2026-10-23 |
| 13 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.01% | $4.5M | — | 2026-10-23 |
| 14 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.05% | $4.4M | — | 2026-05-31 |
| 15 | XHS State Street® SPDR® S&P® Health Care Services ETF | SPDR (State Street) | 1.88% | $4.2M | $221.7M | 2026-10-23 |
| 16 | VHT Vanguard Health Care ETF | Vanguard | 0.02% | $3.3M | — | 2026-09-30 |
| 17 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.09% | $2.5M | — | 2026-07-31 |
| 18 | PSC Principal U.S. Small-Cap ETF | Nport | 0.11% | $2.5M | — | 2026-06-30 |
| 19 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 0.15% | $2.1M | $1.4B | 2026-10-23 |
| 20 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $1.7M | $96.5B | 2026-10-23 |
| 21 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $1.1M | — | 2026-10-23 |
| 22 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.08% | $1.0M | — | 2026-09-30 |
| 23 | FYX First Trust Small Cap Core AlphaDEX® Fund | First Trust | 0.07% | $958,324 | $1.4B | 2026-10-23 |
| 24 | RSSL Global X Russell 2000 ETF | Global X | 0.06% | $917,515 | — | 2026-10-26 |
| 25 | VT Vanguard Total World Stock ETF | Vanguard | 0.00% | $893,519 | — | 2026-09-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-0.59
TTM Revenue
$3.34B
TTM Net Income
$-76.10M
TTM Op. Cash Flow
$280.00M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '26 | 2026-03-31 | $810.90M | $-35.90M | $-0.28 | $11.70M |
| Q4 '25 | 2025-12-31 | $885.00M | $-15.00M | $-0.11 | $103.40M |
| Q3 '25 | 2025-09-30 | $821.50M | $-22.70M | $-0.18 | $83.60M |
| Q2 '25 | 2025-06-30 | $826.20M | $-2.50M | $-0.02 | $81.30M |
| Q1 '25 | 2025-03-31 | $776.00M | $-37.70M | $-0.30 | $6.00M |
| Q4 '24 | 2024-12-31 | $864.40M | $-108.50M | $-0.86 | $111.40M |
| Q3 '24 | 2024-09-30 | $770.40M | $-31.70M | $-0.25 | $65.20M |
| Q2 '24 | 2024-06-30 | $762.10M | $-15.50M | $-0.12 | $82.80M |
| Q1 '24 | 2024-03-31 | $717.40M | $-12.40M | $-0.10 | $40.70M |
| Q4 '23 | 2023-12-31 | $735.40M | $-1.00M | $0.00 | $62.60M |
| Q3 '23 | 2023-09-30 | $674.10M | $-4.90M | $-0.04 | $104.60M |
| Q2 '23 | 2023-06-30 | $667.60M | $18.90M | $0.15 | $52.10M |
Q1 2026 • period ending 2026-03-31 • filed 2026-05-05
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
0.96
P/S
0.89
EV/EBITDA
9.80
EV/Sales
1.91
ROE
-2.5%
ROA
-0.9%
Div Yield
0.00%
FCF Yield
9.45%
Debt/Equity
1.17
Current Ratio
—
Market Cap
$2.96B
as of 2026-10-26
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
14.35M
SI % of Float
18.34%
Days to Cover
5.35
Short Vol Ratio
19.9%
Free Float
78.25M
Float %
59.8%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-14